{"id":"NCT01905683","sponsor":"Merz Pharmaceuticals GmbH","briefTitle":"Long-term Open-label Study of Botulinumtoxin Type A to Treat Spasticity of Leg(s) or Leg(s) and Arm in Cerebral Palsy","officialTitle":"Open-label, Non-controlled, Multicenter Long-term Study to Investigate the Safety and Efficacy of Xeomin® (Incobotulinumtoxin A, NT 201) for the Treatment of Spasticity of the Lower Limb(s) or of Combined Spasticity of Upper and Lower Limb in Children and Adolescents (Age 2 - 17 Years) With Cerebral Palsy","status":"COMPLETED","phase":"PHASE3","dates":{"start":"2013-08","primaryCompletion":"2017-01","completion":"2017-01","firstPosted":"2013-07-23","resultsPosted":"2017-10-27","lastUpdate":"2017-10-27"},"enrollment":370,"design":{"allocation":"NA","model":"SINGLE_GROUP","masking":"NONE","primaryPurpose":"TREATMENT"},"conditions":["Lower Limb and Combined Lower Limb and Upper Limb Spasticity Due to Cerebral Palsy"],"interventions":[{"type":"DRUG","name":"IncobotulinumtoxinA (16-20 Units per kg body weight)","otherNames":["Xeomin","NT 201","Botulinum toxin type A (150 kiloDalton), free from complexing proteins"]}],"arms":[{"label":"16-20 Units per kg body weight incobotulinumtoxinA","type":"EXPERIMENTAL"}],"summary":"The purpose of this study is to determine whether injections of Botulinum toxin type A into muscles of the leg(s) or of leg(s) and one arm are safe in treating children/adolescents (age 2-17 years) long-term with increased muscle tension/uncontrollable muscle stiffness (spasticity) due to cerebral palsy.","primaryOutcome":{"measure":"Occurrence of Treatment Emergent Adverse Events (TEAEs) Overall and Per Injection Cycle","timeFrame":"From the timepoint of first injection up to end of study visit (Week 50-66)","effectByArm":[{"arm":"16 - 20 U/kg Body Weight IncobotulinumtoxinA (Xeomin)","deltaMin":53,"sd":null}],"pValues":[]},"eligibility":{"minAge":"2 Years","sex":"ALL","healthyVolunteers":false,"inclusionCount":null,"exclusionCount":null},"locations":{"siteCount":43,"countries":["Austria","Czechia","Estonia","Germany","Israel","Poland","Romania","Russia","Slovakia","South Korea","Turkey (Türkiye)","Ukraine"]},"refs":{"pmids":["36136523"],"seeAlso":[]},"adverseEventsSummary":{"seriousAny":{"events":16,"n":370},"commonTop":["Nasopharyngitis"]}}